Alendronate-mineralized nanoparticles loaded with ALK-PROTAC reverse the resistance and rebound effects of ALK+ NSCLC to PROTAC therapy by disrupting the mitochondria-linked feedback
- DOI
- 10.1016/j.ajps.2026.101205
- Published
- 2026-10
- Container
- Asian Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ajps.2026.101205,
title = {Alendronate-mineralized nanoparticles loaded with ALK-PROTAC reverse the resistance and rebound effects of ALK+ NSCLC to PROTAC therapy by disrupting the mitochondria-linked feedback},
author = {Jing Zhang and Liuqing Yang and Zhicheng Yan and Qinghua Wu and Xiaojia Jiao and Meifang Chen and Hua Zhang and Wenbing Dai and Xueqing Wang and Qiang Zhang and Bing He},
year = {2026},
journal = {Asian Journal of Pharmaceutical Sciences},
doi = {10.1016/j.ajps.2026.101205},
url = {https://doi.org/10.1016/j.ajps.2026.101205}
}RIS
TY - JOUR TI - Alendronate-mineralized nanoparticles loaded with ALK-PROTAC reverse the resistance and rebound effects of ALK+ NSCLC to PROTAC therapy by disrupting the mitochondria-linked feedback AU - Jing Zhang AU - Liuqing Yang AU - Zhicheng Yan AU - Qinghua Wu AU - Xiaojia Jiao AU - Meifang Chen AU - Hua Zhang AU - Wenbing Dai AU - Xueqing Wang AU - Qiang Zhang AU - Bing He PY - 2026 JO - Asian Journal of Pharmaceutical Sciences DO - 10.1016/j.ajps.2026.101205 UR - https://doi.org/10.1016/j.ajps.2026.101205 ER -
APA
Zhang, J., Yang, L., Yan, Z., Wu, Q., Jiao, X., Chen, M., Zhang, H., Dai, W., Wang, X., Zhang, Q., & He, B. (2026). Alendronate-mineralized nanoparticles loaded with ALK-PROTAC reverse the resistance and rebound effects of ALK+ NSCLC to PROTAC therapy by disrupting the mitochondria-linked feedback. Asian Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.ajps.2026.101205
Source records
- crossref · retrieved 2026-11-09T13:31:16.765Z